These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28411263)

  • 1. Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study.
    Adeeb N; Griessenauer CJ; Foreman PM; Moore JM; Shallwani H; Motiei-Langroudi R; Alturki A; Siddiqui AH; Levy EI; Harrigan MR; Ogilvy CS; Thomas AJ
    Stroke; 2017 May; 48(5):1322-1330. PubMed ID: 28411263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining a Clopidogrel Response Cut-Off Value Using Light Transmission Aggregometry Before Pipeline Embolization of Unruptured Intracranial Aneurysms.
    Adeeb N; Gupta R; Schneider AM; Leadon M; Enriquez A; Griessenauer CJ; Salem M; Alturki A; Schmalz P; Ogilvy CS; Thomas AJ; Moore JM
    World Neurosurg; 2018 May; 113():e146-e152. PubMed ID: 29425984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device.
    McTaggart RA; Choudhri OA; Marcellus ML; Brennan T; Steinberg GK; Dodd RL; Do HM; Marks MP
    J Neurointerv Surg; 2015 Jun; 7(6):425-30. PubMed ID: 24739599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiplatelet therapy on thromboembolism after flow diversion with the pipeline embolization device.
    Heller RS; Dandamudi V; Lanfranchi M; Malek AM
    J Neurosurg; 2013 Dec; 119(6):1603-10. PubMed ID: 23971953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y
    Kim CH; Hwang G; Kwon OK; Ban SP; Chinh ND; Tjahjadi M; Oh CW; Bang JS; Kim T
    Radiology; 2017 Feb; 282(2):542-551. PubMed ID: 27603789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicenter Cohort Comparison Study of the Safety, Efficacy, and Cost of Ticagrelor Compared to Clopidogrel in Aneurysm Flow Diverter Procedures.
    Moore JM; Adeeb N; Shallwani H; Gupta R; Patel AS; Griessenauer CJ; Youn R; Siddiqui A; Ogilvy CS; Thomas AJ
    Neurosurgery; 2017 Oct; 81(4):665-671. PubMed ID: 28475757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant stroke in a ticagrelor non-responder as a complication following aneurysm treatment with the Pipeline Embolization Device™.
    Ghamasaee P; Carr K; Johnson J; Grandhi R
    Interv Neuroradiol; 2017 Jun; 23(3):297-300. PubMed ID: 28391744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy-Mediated Antiplatelet Management Protocol Compared to One-time Platelet Function Testing Prior to Pipeline Embolization of Cerebral Aneurysms: A Propensity Score-Matched Cohort Study.
    Griessenauer CJ; Jain A; Enriquez-Marulanda A; Gupta R; Adeeb N; Moore JM; Grassi SA; Dalal SS; Ogilvy CS; Thomas AJ; Schirmer CM
    Neurosurgery; 2019 Mar; 84(3):673-679. PubMed ID: 29608747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device.
    Delgado Almandoz JE; Crandall BM; Scholz JM; Fease JL; Anderson RE; Kadkhodayan Y; Tubman DE
    AJNR Am J Neuroradiol; 2014 Jan; 35(1):128-35. PubMed ID: 23828107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Function Testing with a VerifyNow-Directed Personalized Antiplatelet Strategy and Associated Rates of Thromboembolic Complications After Pipeline Embolization for Complex Cerebral Aneurysms.
    Neyens R; Donaldson C; Andrews C; Kellogg R; Spiotta A
    World Neurosurg; 2020 Jun; 138():e674-e682. PubMed ID: 32194270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms.
    Delgado Almandoz JE; Kadkhodayan Y; Crandall BM; Scholz JM; Fease JL; Tubman DE
    J Neurointerv Surg; 2014 Dec; 6(10):767-73. PubMed ID: 24353331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Dual-Antiplatelet Regimen for Pipeline Embolization Device Placement: A Survey of Major Academic Neurovascular Centers in the United States.
    Gupta R; Moore JM; Griessenauer CJ; Adeeb N; Patel AS; Youn R; Poliskey K; Thomas AJ; Ogilvy CS
    World Neurosurg; 2016 Dec; 96():285-292. PubMed ID: 27641263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiplatelet therapy and platelet function testing on hemorrhagic and thrombotic complications in patients with cerebral aneurysms treated with the pipeline embolization device: a review and meta-analysis.
    Skukalek SL; Winkler AM; Kang J; Dion JE; Cawley CM; Webb A; Dannenbaum MJ; Schuette AJ; Asbury B; Tong FC
    J Neurointerv Surg; 2016 Jan; 8(1):58-65. PubMed ID: 25385746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms?
    Kang HS; Han MH; Kwon BJ; Jung C; Kim JE; Kwon OK; Oh CW
    Neurosurgery; 2010 Nov; 67(5):1371-6; discussion 1376. PubMed ID: 20871459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of alternatives to clopidogrel in flow-diversion treatment with the Pipeline embolization device.
    Atallah E; Saad H; Bekelis K; Chalouhi N; Tjoumakaris S; Hasan D; Eller J; Stidd D; Rosenwasser RH; Jabbour P
    J Neurosurg; 2018 Nov; 129(5):1130-1135. PubMed ID: 29219758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Preprocedural Platelet Function Testing on Periprocedural Complication Rates Associated With Pipeline Flow Diversion: An International Multicenter Study.
    Vranic JE; Dmytriw AA; Berglar IK; Alotaibi NM; Cancelliere NM; Stapleton CJ; Rabinov JD; Harker P; Gupta R; Bernstock JD; Koch MJ; Raymond SB; Mascitelli JR; Patterson TT; Seinfeld J; White A; Case D; Roark C; Gandhi CD; Al-Mufti F; Cooper J; Matouk C; Sujijantarat N; Devia DA; Ocampo-Navia MI; Villamizar-Torres DE; Puentes JC; Salem MM; Baig A; El Namaani K; Kühn AL; Pukenas B; Jankowitz BT; Burkhardt JK; Siddiqui A; Jabbour P; Singh J; Puri AS; Regenhardt RW; Mendes Pereira V; Patel AB
    Neurosurgery; 2024 Jul; 95(1):179-185. PubMed ID: 38634693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of a 600-mg Loading Dose of Clopidogrel 24 Hours Before Pipeline Embolization Device Treatment.
    Atallah E; Saad H; Bekelis K; Chalouhi N; Tjoumakaris S; Hasan D; Zarzour H; Smith M; Rosenwasser RH; Jabbour P
    World Neurosurg; 2017 Oct; 106():529-535. PubMed ID: 28712897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures.
    Nakagawa I; Park HS; Yokoyama S; Wada T; Hironaka Y; Motoyama Y; Takayama K; Kichikawa K; Nakase H
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):163-71. PubMed ID: 26493334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms: clinical implications.
    Kang HS; Kwon BJ; Kim JE; Han MH
    AJNR Am J Neuroradiol; 2010 Aug; 31(7):1206-10. PubMed ID: 20223886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms.
    Yamada NK; Cross DT; Pilgram TK; Moran CJ; Derdeyn CP; Dacey RG
    AJNR Am J Neuroradiol; 2007 Oct; 28(9):1778-82. PubMed ID: 17885244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.